1a,1b-dihomo-PGF2,
1a,1b-dihomo-PGF2alpha,
1a,1b-dihomoprostaglandin F(2),
1a,1b-dihomoprostaglandin F2,
1a,1b-Dihomo-PGF2alpha,
1a,1b-dihomo Prostaglandin F2alpha,
57944-39-5,
1a,1b-dihomo-9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid,
1a,1b-Dihomoprostaglandin F2,
1a,1b-Dihomo-PGF2,
1a,1b-Dihomoprostaglandin F(2),
AC1O5ZPT,
SCHEMBL3368086,
HMS3648P13,
1a,1b-dihomo-Prostaglandin F2alpha,
1283AH,
LMFA03010157,
ZINC33956029,
SR-01000946468,
SR-01000946468-1,
(7Z)-9-[(1R)-2beta-[(1E,3S)-3-Hydroxy-1-octenyl]-3alpha,5alpha-dihydroxycyclopentane-1alpha-yl]-7-nonenoic acid,
(Z)-9-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]non-7-enoic acid,
7-Nonenoic acid, 9-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-,
FA(22:2(OH3,cyclo)),
C22H38O5,
CID6443812,